Omaha, NENCT06938581Now EnrollingIRB Ready

Breast Cancer Clinical Trial in Omaha, NE

Access cutting-edge breast cancer treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.

Sponsored by University of Nebraska

Quick Self-Assessment

See if you qualify for this Omaha location

Preparing your pre-screening questions…

Expert Care in Omaha

Access breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast cancer treatment provided free

Apply for This Omaha Location

Check if you qualify for this breast cancer clinical trial in Omaha, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Omaha

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Omaha site if eligible
  4. 4Begin participation

About This Breast Cancer Study in Omaha

Enhanced Recovery After Surgery (ERAS) protocols have been of increasing interest in the surgical community for decades. The emphasis has been development of protocols to maximize pain control post-operatively without the use of opioids. While this approach has been studied extensively in the oncology surgery literature, little data exists on the utility of ERAS protocols in the setting of breast conserving surgery (BCS), which is a type of surgery to remove breast cancer while saving as much of the breast as possible. The purpose of this study is to determine the utility of implementing ERAS protocols in breast cancer patients undergoing breast conserving surgery. Study participants will be randomized to either ERAS protocol or standard peri-operative care without ERAS. The study will assess the how many opioid prescriptions are given in the first week after surgery and how much pain participants report right after surgery. Investigators will also look at how long participants stay in the recovery room and if medicine for nausea is needed.

Sponsor: University of Nebraska

Who Can Participate

Inclusion Criteria

Males or females 19 years of age or older
Able to provide study-specific informed consent
Histologic confirmation of breast cancer on core needle biopsy
Clinical or radiographic cT1-T3 N0 disease
Undergoing breast conserving surgery with lumpectomy \& sentinel lymph node biopsy
No prior definitive treatment or intervention
Able to swallow and retain oral carbohydrate drinks and medication

Exclusion Criteria

Contraindications to ERAS protocol components
Undergoing lumpectomy without sentinel lymph node biopsy, mastectomy, or other specified procedures
Diagnosed with cT4 or N1-3 disease
Metastatic disease at presentation
Taking opioid pain medications for other indications
History of substance use disorder
Any condition where ERAS could compromise safety

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Omaha?

Yes, this clinical trial (NCT06938581) has an active research site in Omaha, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer Treatment Options in Omaha, NE

If you're searching for breast cancer treatment options in Omaha, NE, this clinical trial (NCT06938581) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Omaha, NE

See all breast cancer clinical trials recruiting in Omaha — not just this study.

Browse Breast Cancer Trials in Omaha →

Ready to Join in Omaha?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Omaha, NE